Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Mars, Incorporated to acquire VCA Inc.
hand shake
The transaction is expected to complete later in 2017.
Transaction price set at around $9.1 billion

Mars, Incorporated has entered an agreement to acquire VCA Inc., which owns nearly 800 animal hospitals in the US and Canada.

Mars is set to acquire all outstanding shares of VCA for $93 per share - a total value of around $9.1 billion, which includes $1.4 billion in outstanding debt.

When the acquisition is complete VCA will operate as a distinct business unit within Mars Petcare, alongside other veterinary businesses; Banfield Pet Hospital, Bluepearl and Pet Partners. VCA will continue to be led by Bob Antin, its chief executive officer, president, chairman and founder.

Since it was founded in 1986, VCA has grown to nearly 800 veterinary hospitals with 60 diagnostic laboratories. The company operates across four divisions: veterinary services, laboratory diagnostics, imaging equipment and medical technology and pet care services.

Mars CEO Grant F Reid commented: “We are thrilled to welcome VCA to the Mars family and to our portfolio of brands and businesses around the world.

“VCA is a leader across pet health care and the opportunity we see together - for pets, pet owners, veterinarians and other pet care providers - is tremendous.

“We have great respect for VCA, with whom we share many common values and a strong commitment to pet care. Together, we will be able to provide even greater value, better service and higher quality care to pets and pet owners.”

The transaction is subject to VCA shareholder approval, customary regulatory approval, and other conditions. It is expected to complete later in 2017.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.